This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2020 Feb 20;7(1):e000302corr1.

doi: 10.1136/bmjgast-2019-000302corr1. eCollection 2020.

Correction: Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation

No authors listed

PMID: 32128231
PMCID: PMC7039591
DOI: 10.1136/bmjgast-2019-000302corr1

Published Erratum

Correction: Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation

No authors listed. BMJ Open Gastroenterol. 2020.

. 2020 Feb 20;7(1):e000302corr1.

doi: 10.1136/bmjgast-2019-000302corr1. eCollection 2020.

PMID: 32128231
PMCID: PMC7039591
DOI: 10.1136/bmjgast-2019-000302corr1

Abstract

[This corrects the article DOI: 10.1136/bmjgast-2019-000302.].

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

PubMed Disclaimer

Erratum for

Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation.
Lohan C, Diamantopoulos A, LeReun C, Wright E, Bohm N, Sawyer LM. Lohan C, et al. BMJ Open Gastroenterol. 2019 Jul 30;6(1):e000302. doi: 10.1136/bmjgast-2019-000302. eCollection 2019. BMJ Open Gastroenterol. 2019. PMID: 31413856 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources